CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 17 No. 10
Pages: 1  2  
Next
NEWS & ANALYSIS 

ACS spends big money to highlight healthcare system deficiencies

By Daniel I. Jacobs, BA, and
Charles L. Bennett, MD, PhD, MPP
| October 1, 2008
Dr. Bennett is the AC Buehler Professor of Geriatrics and Economics at the Jesse Brown VA Medical Center-Lakeside BCOC; member of the National Council of Advisors to the American Cancer Society; professor of medicine, division of hematology/oncology, Northwestern University Feinberg School of Medicine; associate director, Mid-West Center for Health Services and Policy Research; and co-director of the cancer control program at the Robert H. Lurie Comprehensive Cancer Center, Northwestern University. Mr. Jacobs is a project coordinator in the Bennett group.
Billion dollar cancer advocacy behemoth calls for major overhaul of insurance coverage.

With the race for the presidency in full swing, the American Cancer Society (ACS) is taking a leading role in increasing the nation’s focus on the country’s ailing health care system.

Last fall, the organization and its advocacy partner the American Cancer Society Cancer Action Network (ACS CAN) initiated a public education campaign to highlight the dangers of inadequate (or nonexistent) health insurance and engage policymakers at the state and federal level on the need to put health care reform at the top of the political agenda.

The “ACS CAN Fight Back Express” bus has been on a nationwide tour to raise awareness about the need for change, and to educate policymakers on the ways in which the system needs to change and why. Additionally, the Society spent $15 million this year on a series of commercials which have run on major news networks and recently during local telecasts of the Republican and Democratic National Conventions, attempting to convey the severity of the health care system’s failures. With a mission to prevent cancer, save lives, and diminish suffering from cancer, the ACS makes the case that the nation’s progress in the fight is insufficient to achieve its goals.

Not up to the challenge

The ACS cites a lack of early detection as one of the major reasons that cancer mortality rates have not dropped as quickly as desired over the past few years. Given that rates of early detection of malignancies are higher for the insured than the uninsured, the ACS claims that a faulty healthcare system contributes to the slowed progress.1

Approximately 47 million Americans, or nearly 16% of the population, are uninsured. Roughly one in every 10 individuals battling cancer is among the uninsured forced to bear the enormous costs alone.1 As noted in one poignant commercial, this burden can often drive a family into considerable debt.

ACS CEO John Seffrin, PhD, argues that high-quality care for individuals battling cancer, as well as meaningful progress in cancer treatment, is realistic. However, advancement is limited by an inextricable link to a healthcare system which is “not up to this challenge.”2

A call for action

Most Americans will agree that the US healthcare system is economically flawed. Costs are high, rising, and unsustainable, while there is little hope for major improvement without equivalently major change. In a statement issued to legislators and the media, the ACS suggests that the system “must be reoriented to emphasize wellness and healthy outcomes” through redesigned health insurance plans and realistic long-term financing.3

The organization calls for a system providing meaningful public or private health insurance for all individuals. It defines “meaningful health insurance” through the “4 As” (see Table).

Table

Additionally, the system should not allow for “cherry picking,” or discrimination among applicants by insurers. In order for a new system to work, incentives need to be restructured to encourage healthy behavior and early detection of cancer and other serious medical conditions. With these stipulations in mind, the ACS proposes the implementation of a research program to look further into approaches to contain costs and increase the value of a healthcare program.4

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy